Internal Medicine, Rheumatology · Brooklyn, NY
NPI
1508818212
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1664 E 14th St, Suite 401
Brooklyn, NY, 11229
Phone (718) 375-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$576K
63,165 services
Medicare patients, 2024
355
Average age 73
Drug cost, 2024
$13.8M
9,961 prescriptions
Company payments, 2025
$3,581
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victoria Katz was code 97530 (pt treatment), 2,537 times for 59 patients. In total Victoria Katz billed 63,165 services in 76 codes, and Medicare paid $576K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 97530 PT Treatment | Office | 2,537 | 59 | $24.30 | $62K |
| 96401 Chemotherapy Administration | Office | 2,300 | 115 | $62.91 | $145K |
| J9260 Injection, methotrexate sodium, 50 mg | Office | 1,585 | 94 | $0.59 | $932 |
| 99213 Office E&M - Established | Office | 654 | 238 | $72.29 | $47K |
| 96372 Injection Administration | Office | 437 | 63 | $12.16 | $5,312 |
| 99214 Office E&M - Established | Office | 396 | 210 | $104.43 | $41K |
| 20611 Joint Injection | Office | 371 | 70 | $84.71 | $31K |
| 36415 Venipuncture Blood Collection | Office | 318 | 184 | $8.65 | $2,751 |
| J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 286 | 50 | $56.96 | $16K |
| 96413 Chemotherapy Administration | Office | 185 | 20 | $113.92 | $21K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 179 | 30 | $0.51 | $91.52 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 140 | 58 | $0.74 | $104 |
| 96365 Intravenous Infusion, Hydration | Office | 102 | 30 | $54.95 | $5,605 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 81 | 21 | $1.02 | $82.67 |
| 96360 Intravenous Infusion, Hydration | Office | 80 | 21 | $28.58 | $2,287 |
By year: 2022 $396K for 8,122 services; 2023 $462K for 11,247 services; 2024 $576K for 63,165 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 318 | 184 | $8.65 | $2,751 |
Medicare prescription drug claims, 2024
In 2024, the drug Victoria Katz prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,059 prescriptions and refills. In total Victoria Katz wrote 9,961 Medicare prescriptions that cost $13.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,059 | 1,246 | 221 | $26K |
| Methotrexate Sodium Methotrexate Sodium/Pf | 564 | 571 | 153 | $5,026 |
| Repatha Sureclick Evolocumab | 527 | 545 | 122 | $289K |
| Vascepa Icosapent Ethyl | 510 | 554 | 116 | $163K |
| Diclofenac Sodium Generic | 446 | 497 | 116 | $187K |
| Methotrexate Methotrexate Sodium | 441 | 508 | 109 | $5,001 |
| Atorvastatin Calcium Generic | 367 | 525 | 112 | $1,873 |
| Icosapent Ethyl Generic | 364 | 400 | 113 | $50K |
| Alendronate Sodium Generic | 298 | 448 | 71 | $1,573 |
| Famotidine Generic | 249 | 300 | 77 | $1,513 |
| Benlysta Belimumab | 247 | 247 | 29 | $868K |
| Prednisone Generic | 190 | 215 | 78 | $855 |
| Mycophenolate Mofetil Generic | 177 | 215 | 38 | $16K |
| Humira(Cf) Pen Adalimumab | 152 | 152 | 25 | $1.0M |
| Ztlido Lidocaine | 148 | 154 | 47 | $57K |
Brand drugs: 3,284 claims; generic drugs: 6,638 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victoria Katz $3,581 ($3,581 in general payments such as food, travel and fees) from 10 companies. The largest payer was Amgen Inc. with $744.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 42 | $744 |
| Janssen Biotech, Inc. JNJ | 48 | $694 |
| Abbvie Inc. ABBV | 37 | $661 |
| Mallinckrodt Hospital Products Inc. | 27 | $524 |
| ANI Pharmaceuticals, Inc. ANIP | 33 | $387 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $220 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $206 |
| Lilly USA, LLC LLY | 3 | $73 |
| Scilex Pharmaceuticals Inc. | 3 | $56.31 |
| GlaxoSmithKline, LLC. GSK | 1 | $17.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.